Latest KFF Health News Stories
Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk
Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.
Medicaid Expansion Making Diabetes Meds More Accessible To Poor, Study Shows
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
Expansión de Medicaid facilita el acceso de los más pobres a drogas anti diabetes
El estudio revela que las recetas para drogas contra la diabetes aumentaron un 40% en los estados que expandieron Medicaid bajo ACA. También lo hicieron los diagnósticos.
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
To Tame Prescription Prices, HHS Dips A Toe Into Drug Importation Stream
The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Congress And Health Care. Again.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.
Déjà Voodoo: Pharma’s Promises To Curb Drug Prices Have Been Heard Before
Several major drugmakers vow to contain drug prices, but similar pledges since the 1990s have not had much impact.
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Drug Prices And Unicorns
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of Stat News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.
Staggering Prices Slow Insurers’ Coverage Of CAR-T Cancer Therapy
Some state Medicaid programs are not paying for the procedures, and Medicare’s complicated payment rates have hospitals concerned that it will not cover all the costs.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Esperanza y cautela por una vacuna de bajo costo contra la diabetes tipo 1
La vacuna, conocida como BCG, se utiliza en varios países para prevenir la tuberculosis y durante mucho tiempo se ha sabido que también estimula el sistema inmunitario.
Retooled Vaccine Raises Hopes As A Lower-Cost Treatment For Type 1 Diabetes
The vaccine, BCG, is relatively cheap. But experts caution the therapy could be overhyped and, if proven effective, wind up overpriced.
Podcast: KHN’s ‘What The Health?’ ACA Under Fire. Again.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administration’s efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
Can Insurers Use Genetic Testing Results? A Reader Wants To Know
Other readers ask what can be done to challenge unexpected medical bills — whether the result of an emergency room visit or after a change in prescription drug coverage.
State Prisons Fail To Offer Cure To 144,000 Inmates With Deadly Hepatitis C
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, can’t get the expensive drugs they need to cure it.
Podcast: KHN’s ‘What The Health?’ Whither Work Requirements?
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Anna Edney of Bloomberg News discuss the latest enrollment numbers for the Affordable Care Act, Medicaid work requirements in Kentucky and President Donald Trump’s proposed government reorganization plan. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
Gastos de bolsillo impiden que más personas reciban la droga que previene el VIH
Funcionarios de salud pública están intensificando esfuerzos para que más personas puedan consumir PrEP. Pero aseguradoras ponen trabas al uso de cupones.
Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk
It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.
